Resverlogix Corp.
Resverlogix Corp. (RVXCF) Stock Competitors & Peer Comparison
See (RVXCF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RVXCF | $0.08 | +0.00% | 17.4M | -6.10 | -$0.01 | N/A |
| NONOF | $45.50 | -5.52% | 223.5B | 13.01 | $3.87 | +3.25% |
| CSLLY | $87.61 | +1.34% | 165.7B | 31.46 | $2.72 | +1.55% |
| CMXHF | $178.56 | -0.25% | 79.2B | 30.02 | $5.45 | +1.69% |
| UCBJF | $222.09 | -0.45% | 42.4B | 28.44 | $7.85 | +0.71% |
| UCBJY | $106.37 | -0.95% | 41.3B | 26.87 | $4.01 | +0.73% |
| ARGNF | $547.60 | +0.00% | 33.5B | 27.85 | $19.66 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| IVBXF | $12.69 | +4.44% | 22.3B | -1304.00 | -$0.01 | N/A |
| SBHMY | $18.65 | +0.00% | 16.7B | 64.31 | $0.29 | +0.96% |
Stock Comparison
RVXCF vs NONOF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, NONOF has a market cap of 223.5B. Regarding current trading prices, RVXCF is priced at $0.08, while NONOF trades at $45.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas NONOF's P/E ratio is 13.01. In terms of profitability, RVXCF's ROE is +0.06%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, RVXCF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check NONOF's competition here
RVXCF vs CSLLY Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CSLLY has a market cap of 165.7B. Regarding current trading prices, RVXCF is priced at $0.08, while CSLLY trades at $87.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CSLLY's P/E ratio is 31.46. In terms of profitability, RVXCF's ROE is +0.06%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, RVXCF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check CSLLY's competition here
RVXCF vs CMXHF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CMXHF has a market cap of 79.2B. Regarding current trading prices, RVXCF is priced at $0.08, while CMXHF trades at $178.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CMXHF's P/E ratio is 30.02. In terms of profitability, RVXCF's ROE is +0.06%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, RVXCF and CMXHF have similar daily volatility (0.00).Check CMXHF's competition here
RVXCF vs UCBJF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, UCBJF has a market cap of 42.4B. Regarding current trading prices, RVXCF is priced at $0.08, while UCBJF trades at $222.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas UCBJF's P/E ratio is 28.44. In terms of profitability, RVXCF's ROE is +0.06%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, RVXCF and UCBJF have similar daily volatility (0.00).Check UCBJF's competition here
RVXCF vs UCBJY Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, UCBJY has a market cap of 41.3B. Regarding current trading prices, RVXCF is priced at $0.08, while UCBJY trades at $106.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas UCBJY's P/E ratio is 26.87. In terms of profitability, RVXCF's ROE is +0.06%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, RVXCF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check UCBJY's competition here
RVXCF vs ARGNF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ARGNF has a market cap of 33.5B. Regarding current trading prices, RVXCF is priced at $0.08, while ARGNF trades at $547.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ARGNF's P/E ratio is 27.85. In terms of profitability, RVXCF's ROE is +0.06%, compared to ARGNF's ROE of +0.19%. Regarding short-term risk, RVXCF and ARGNF have similar daily volatility (0.00).Check ARGNF's competition here
RVXCF vs ODTC Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, RVXCF is priced at $0.08, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ODTC's P/E ratio is 1.07. In terms of profitability, RVXCF's ROE is +0.06%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, RVXCF and ODTC have similar daily volatility (0.00).Check ODTC's competition here
RVXCF vs IVBXF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, IVBXF has a market cap of 22.3B. Regarding current trading prices, RVXCF is priced at $0.08, while IVBXF trades at $12.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas IVBXF's P/E ratio is -1304.00. In terms of profitability, RVXCF's ROE is +0.06%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, RVXCF is less volatile compared to IVBXF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check IVBXF's competition here
RVXCF vs SBHMY Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, SBHMY has a market cap of 16.7B. Regarding current trading prices, RVXCF is priced at $0.08, while SBHMY trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas SBHMY's P/E ratio is 64.31. In terms of profitability, RVXCF's ROE is +0.06%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, RVXCF and SBHMY have similar daily volatility (0.00).Check SBHMY's competition here
RVXCF vs SBMFF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, SBMFF has a market cap of 16.6B. Regarding current trading prices, RVXCF is priced at $0.08, while SBMFF trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas SBMFF's P/E ratio is 92.88. In terms of profitability, RVXCF's ROE is +0.06%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, RVXCF and SBMFF have similar daily volatility (0.00).Check SBMFF's competition here
RVXCF vs WXIBF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, WXIBF has a market cap of 15.7B. Regarding current trading prices, RVXCF is priced at $0.08, while WXIBF trades at $3.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas WXIBF's P/E ratio is 35.00. In terms of profitability, RVXCF's ROE is +0.06%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, RVXCF and WXIBF have similar daily volatility (0.00).Check WXIBF's competition here
RVXCF vs WXXWY Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, WXXWY has a market cap of 15.3B. Regarding current trading prices, RVXCF is priced at $0.08, while WXXWY trades at $7.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas WXXWY's P/E ratio is 34.09. In terms of profitability, RVXCF's ROE is +0.06%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, RVXCF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check WXXWY's competition here
RVXCF vs GNMSF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, GNMSF has a market cap of 13.3B. Regarding current trading prices, RVXCF is priced at $0.08, while GNMSF trades at $216.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas GNMSF's P/E ratio is 12.69. In terms of profitability, RVXCF's ROE is +0.06%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, RVXCF and GNMSF have similar daily volatility (0.00).Check GNMSF's competition here
RVXCF vs TRSBF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, TRSBF has a market cap of 9.6B. Regarding current trading prices, RVXCF is priced at $0.08, while TRSBF trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas TRSBF's P/E ratio is 33.33. In terms of profitability, RVXCF's ROE is +0.06%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, RVXCF is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check TRSBF's competition here
RVXCF vs AKBLF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, AKBLF has a market cap of 6.4B. Regarding current trading prices, RVXCF is priced at $0.08, while AKBLF trades at $28.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas AKBLF's P/E ratio is 44.54. In terms of profitability, RVXCF's ROE is +0.06%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, RVXCF and AKBLF have similar daily volatility (0.00).Check AKBLF's competition here
RVXCF vs AAVXF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, AAVXF has a market cap of 5.4B. Regarding current trading prices, RVXCF is priced at $0.08, while AAVXF trades at $71.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas AAVXF's P/E ratio is -20.76. In terms of profitability, RVXCF's ROE is +0.06%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, RVXCF and AAVXF have similar daily volatility (0.00).Check AAVXF's competition here
RVXCF vs ABCZF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, RVXCF is priced at $0.08, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, RVXCF's ROE is +0.06%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, RVXCF and ABCZF have similar daily volatility (0.00).Check ABCZF's competition here
RVXCF vs INCPF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, RVXCF is priced at $0.08, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas INCPF's P/E ratio is -108.67. In terms of profitability, RVXCF's ROE is +0.06%, compared to INCPF's ROE of -0.04%. Regarding short-term risk, RVXCF and INCPF have similar daily volatility (0.00).Check INCPF's competition here
RVXCF vs GNNSF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, GNNSF has a market cap of 4.7B. Regarding current trading prices, RVXCF is priced at $0.08, while GNNSF trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas GNNSF's P/E ratio is -27.37. In terms of profitability, RVXCF's ROE is +0.06%, compared to GNNSF's ROE of +1.07%. Regarding short-term risk, RVXCF and GNNSF have similar daily volatility (0.00).Check GNNSF's competition here
RVXCF vs LABFF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, RVXCF is priced at $0.08, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas LABFF's P/E ratio is 28.95. In terms of profitability, RVXCF's ROE is +0.06%, compared to LABFF's ROE of +0.35%. Regarding short-term risk, RVXCF and LABFF have similar daily volatility (0.00).Check LABFF's competition here
RVXCF vs CAMRF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CAMRF has a market cap of 4.2B. Regarding current trading prices, RVXCF is priced at $0.08, while CAMRF trades at $71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CAMRF's P/E ratio is 57.26. In terms of profitability, RVXCF's ROE is +0.06%, compared to CAMRF's ROE of +0.21%. Regarding short-term risk, RVXCF and CAMRF have similar daily volatility (0.00).Check CAMRF's competition here
RVXCF vs TLPPF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, TLPPF has a market cap of 3.8B. Regarding current trading prices, RVXCF is priced at $0.08, while TLPPF trades at $11.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas TLPPF's P/E ratio is 124.39. In terms of profitability, RVXCF's ROE is +0.06%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, RVXCF is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check TLPPF's competition here
RVXCF vs ZLDPF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ZLDPF has a market cap of 3.6B. Regarding current trading prices, RVXCF is priced at $0.08, while ZLDPF trades at $50.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ZLDPF's P/E ratio is -18.71. In terms of profitability, RVXCF's ROE is +0.06%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, RVXCF and ZLDPF have similar daily volatility (0.00).Check ZLDPF's competition here
RVXCF vs REGMF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, REGMF has a market cap of 3B. Regarding current trading prices, RVXCF is priced at $0.08, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas REGMF's P/E ratio is -13.32. In terms of profitability, RVXCF's ROE is +0.06%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, RVXCF and REGMF have similar daily volatility (0.00).Check REGMF's competition here
RVXCF vs BVNKF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BVNKF has a market cap of 2.9B. Regarding current trading prices, RVXCF is priced at $0.08, while BVNKF trades at $37.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BVNKF's P/E ratio is 14.26. In terms of profitability, RVXCF's ROE is +0.06%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, RVXCF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check BVNKF's competition here
RVXCF vs BVNRY Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BVNRY has a market cap of 2.9B. Regarding current trading prices, RVXCF is priced at $0.08, while BVNRY trades at $12.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BVNRY's P/E ratio is 14.02. In terms of profitability, RVXCF's ROE is +0.06%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, RVXCF is less volatile compared to BVNRY. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check BVNRY's competition here
RVXCF vs SHJBF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, SHJBF has a market cap of 2.9B. Regarding current trading prices, RVXCF is priced at $0.08, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, RVXCF's ROE is +0.06%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, RVXCF and SHJBF have similar daily volatility (0.00).Check SHJBF's competition here
RVXCF vs TKBIF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, RVXCF is priced at $0.08, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, RVXCF's ROE is +0.06%, compared to TKBIF's ROE of N/A. Regarding short-term risk, RVXCF and TKBIF have similar daily volatility (0.00).Check TKBIF's competition here
RVXCF vs MPSYF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, RVXCF is priced at $0.08, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, RVXCF's ROE is +0.06%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, RVXCF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check MPSYF's competition here
RVXCF vs ONTTF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ONTTF has a market cap of 2.7B. Regarding current trading prices, RVXCF is priced at $0.08, while ONTTF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ONTTF's P/E ratio is -13.52. In terms of profitability, RVXCF's ROE is +0.06%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, RVXCF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check ONTTF's competition here
RVXCF vs GENSF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, GENSF has a market cap of 2.2B. Regarding current trading prices, RVXCF is priced at $0.08, while GENSF trades at $33.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas GENSF's P/E ratio is -416.12. In terms of profitability, RVXCF's ROE is +0.06%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, RVXCF and GENSF have similar daily volatility (0.00).Check GENSF's competition here
RVXCF vs ASPHF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, RVXCF is priced at $0.08, while ASPHF trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ASPHF's P/E ratio is -32.36. In terms of profitability, RVXCF's ROE is +0.06%, compared to ASPHF's ROE of -2.50%. Regarding short-term risk, RVXCF is less volatile compared to ASPHF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check ASPHF's competition here
RVXCF vs BRCTF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BRCTF has a market cap of 2B. Regarding current trading prices, RVXCF is priced at $0.08, while BRCTF trades at $22.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BRCTF's P/E ratio is 21.78. In terms of profitability, RVXCF's ROE is +0.06%, compared to BRCTF's ROE of +0.77%. Regarding short-term risk, RVXCF and BRCTF have similar daily volatility (0.00).Check BRCTF's competition here
RVXCF vs MEOBF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, MEOBF has a market cap of 1.9B. Regarding current trading prices, RVXCF is priced at $0.08, while MEOBF trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas MEOBF's P/E ratio is -15.10. In terms of profitability, RVXCF's ROE is +0.06%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, RVXCF and MEOBF have similar daily volatility (0.00).Check MEOBF's competition here
RVXCF vs GLPGF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, RVXCF is priced at $0.08, while GLPGF trades at $28.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas GLPGF's P/E ratio is -5.65. In terms of profitability, RVXCF's ROE is +0.06%, compared to GLPGF's ROE of -0.10%. Regarding short-term risk, RVXCF and GLPGF have similar daily volatility (0.00).Check GLPGF's competition here
RVXCF vs BIESF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, RVXCF is priced at $0.08, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BIESF's P/E ratio is -44.44. In terms of profitability, RVXCF's ROE is +0.06%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, RVXCF and BIESF have similar daily volatility (0.00).Check BIESF's competition here
RVXCF vs PHMMF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, RVXCF is priced at $0.08, while PHMMF trades at $91.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas PHMMF's P/E ratio is 32.81. In terms of profitability, RVXCF's ROE is +0.06%, compared to PHMMF's ROE of +0.21%. Regarding short-term risk, RVXCF and PHMMF have similar daily volatility (0.00).Check PHMMF's competition here
RVXCF vs PPTDF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, PPTDF has a market cap of 1.4B. Regarding current trading prices, RVXCF is priced at $0.08, while PPTDF trades at $11.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas PPTDF's P/E ratio is -42.69. In terms of profitability, RVXCF's ROE is +0.06%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, RVXCF and PPTDF have similar daily volatility (0.00).Check PPTDF's competition here
RVXCF vs CSBTF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CSBTF has a market cap of 1.4B. Regarding current trading prices, RVXCF is priced at $0.08, while CSBTF trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CSBTF's P/E ratio is -298.67. In terms of profitability, RVXCF's ROE is +0.06%, compared to CSBTF's ROE of -0.06%. Regarding short-term risk, RVXCF and CSBTF have similar daily volatility (0.00).Check CSBTF's competition here
RVXCF vs NURPF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, NURPF has a market cap of 1.4B. Regarding current trading prices, RVXCF is priced at $0.08, while NURPF trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas NURPF's P/E ratio is 15.71. In terms of profitability, RVXCF's ROE is +0.06%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, RVXCF and NURPF have similar daily volatility (0.00).Check NURPF's competition here
RVXCF vs HBMHF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, HBMHF has a market cap of 1.4B. Regarding current trading prices, RVXCF is priced at $0.08, while HBMHF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas HBMHF's P/E ratio is 53.35. In terms of profitability, RVXCF's ROE is +0.06%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, RVXCF and HBMHF have similar daily volatility (0.00).Check HBMHF's competition here
RVXCF vs BRAXF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BRAXF has a market cap of 1.3B. Regarding current trading prices, RVXCF is priced at $0.08, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, RVXCF's ROE is +0.06%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, RVXCF and BRAXF have similar daily volatility (0.00).Check BRAXF's competition here
RVXCF vs ASCLF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ASCLF has a market cap of 1.3B. Regarding current trading prices, RVXCF is priced at $0.08, while ASCLF trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ASCLF's P/E ratio is -32.25. In terms of profitability, RVXCF's ROE is +0.06%, compared to ASCLF's ROE of -0.06%. Regarding short-term risk, RVXCF and ASCLF have similar daily volatility (0.00).Check ASCLF's competition here
RVXCF vs CSPHF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CSPHF has a market cap of 1.2B. Regarding current trading prices, RVXCF is priced at $0.08, while CSPHF trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CSPHF's P/E ratio is -85.50. In terms of profitability, RVXCF's ROE is +0.06%, compared to CSPHF's ROE of +0.04%. Regarding short-term risk, RVXCF and CSPHF have similar daily volatility (0.00).Check CSPHF's competition here
RVXCF vs SNBIF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, SNBIF has a market cap of 1.2B. Regarding current trading prices, RVXCF is priced at $0.08, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas SNBIF's P/E ratio is -39.17. In terms of profitability, RVXCF's ROE is +0.06%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, RVXCF and SNBIF have similar daily volatility (0.00).Check SNBIF's competition here
RVXCF vs BTTAY Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BTTAY has a market cap of 958.8M. Regarding current trading prices, RVXCF is priced at $0.08, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, RVXCF's ROE is +0.06%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, RVXCF is less volatile compared to BTTAY. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check BTTAY's competition here
RVXCF vs BPMUF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BPMUF has a market cap of 831.7M. Regarding current trading prices, RVXCF is priced at $0.08, while BPMUF trades at $67.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BPMUF's P/E ratio is 9.38. In terms of profitability, RVXCF's ROE is +0.06%, compared to BPMUF's ROE of +1.59%. Regarding short-term risk, RVXCF and BPMUF have similar daily volatility (0.00).Check BPMUF's competition here
RVXCF vs IDRSF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, IDRSF has a market cap of 787.8M. Regarding current trading prices, RVXCF is priced at $0.08, while IDRSF trades at $3.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas IDRSF's P/E ratio is -2.08. In terms of profitability, RVXCF's ROE is +0.06%, compared to IDRSF's ROE of +0.20%. Regarding short-term risk, RVXCF and IDRSF have similar daily volatility (0.00).Check IDRSF's competition here
RVXCF vs PHGUF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, PHGUF has a market cap of 781.1M. Regarding current trading prices, RVXCF is priced at $0.08, while PHGUF trades at $1.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas PHGUF's P/E ratio is -114.00. In terms of profitability, RVXCF's ROE is +0.06%, compared to PHGUF's ROE of -0.03%. Regarding short-term risk, RVXCF and PHGUF have similar daily volatility (0.00).Check PHGUF's competition here
RVXCF vs INRLF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, INRLF has a market cap of 722.8M. Regarding current trading prices, RVXCF is priced at $0.08, while INRLF trades at $3.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas INRLF's P/E ratio is -6.54. In terms of profitability, RVXCF's ROE is +0.06%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, RVXCF and INRLF have similar daily volatility (0.00).Check INRLF's competition here
RVXCF vs SOLTF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, SOLTF has a market cap of 562.9M. Regarding current trading prices, RVXCF is priced at $0.08, while SOLTF trades at $6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas SOLTF's P/E ratio is -36.59. In terms of profitability, RVXCF's ROE is +0.06%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, RVXCF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check SOLTF's competition here
RVXCF vs HLOSF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, HLOSF has a market cap of 487M. Regarding current trading prices, RVXCF is priced at $0.08, while HLOSF trades at $4.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas HLOSF's P/E ratio is -14.35. In terms of profitability, RVXCF's ROE is +0.06%, compared to HLOSF's ROE of -0.85%. Regarding short-term risk, RVXCF and HLOSF have similar daily volatility (0.00).Check HLOSF's competition here
RVXCF vs CKDXF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CKDXF has a market cap of 481.6M. Regarding current trading prices, RVXCF is priced at $0.08, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, RVXCF's ROE is +0.06%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, RVXCF and CKDXF have similar daily volatility (0.00).Check CKDXF's competition here
RVXCF vs RAONF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, RVXCF is priced at $0.08, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas RAONF's P/E ratio is -43.33. In terms of profitability, RVXCF's ROE is +0.06%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, RVXCF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check RAONF's competition here
RVXCF vs TBGNF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, RVXCF is priced at $0.08, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, RVXCF's ROE is +0.06%, compared to TBGNF's ROE of N/A. Regarding short-term risk, RVXCF and TBGNF have similar daily volatility (0.00).Check TBGNF's competition here
RVXCF vs PTCHF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, PTCHF has a market cap of 427.1M. Regarding current trading prices, RVXCF is priced at $0.08, while PTCHF trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas PTCHF's P/E ratio is 8.43. In terms of profitability, RVXCF's ROE is +0.06%, compared to PTCHF's ROE of +0.15%. Regarding short-term risk, RVXCF and PTCHF have similar daily volatility (0.00).Check PTCHF's competition here
RVXCF vs CLVLF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CLVLF has a market cap of 396.2M. Regarding current trading prices, RVXCF is priced at $0.08, while CLVLF trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CLVLF's P/E ratio is 15.81. In terms of profitability, RVXCF's ROE is +0.06%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, RVXCF and CLVLF have similar daily volatility (0.00).Check CLVLF's competition here
RVXCF vs CLVLY Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CLVLY has a market cap of 393.6M. Regarding current trading prices, RVXCF is priced at $0.08, while CLVLY trades at $7.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CLVLY's P/E ratio is 15.65. In terms of profitability, RVXCF's ROE is +0.06%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, RVXCF is less volatile compared to CLVLY. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check CLVLY's competition here
RVXCF vs VBIZF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, VBIZF has a market cap of 384.8M. Regarding current trading prices, RVXCF is priced at $0.08, while VBIZF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas VBIZF's P/E ratio is 18.50. In terms of profitability, RVXCF's ROE is +0.06%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, RVXCF and VBIZF have similar daily volatility (0.00).Check VBIZF's competition here
RVXCF vs NWBO Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, NWBO has a market cap of 359.1M. Regarding current trading prices, RVXCF is priced at $0.08, while NWBO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas NWBO's P/E ratio is -4.11. In terms of profitability, RVXCF's ROE is +0.06%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, RVXCF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check NWBO's competition here
RVXCF vs CYDY Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CYDY has a market cap of 322.9M. Regarding current trading prices, RVXCF is priced at $0.08, while CYDY trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CYDY's P/E ratio is -12.90. In terms of profitability, RVXCF's ROE is +0.06%, compared to CYDY's ROE of -0.04%. Regarding short-term risk, RVXCF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check CYDY's competition here
RVXCF vs IVEVF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, IVEVF has a market cap of 317.2M. Regarding current trading prices, RVXCF is priced at $0.08, while IVEVF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas IVEVF's P/E ratio is -0.66. In terms of profitability, RVXCF's ROE is +0.06%, compared to IVEVF's ROE of +0.68%. Regarding short-term risk, RVXCF and IVEVF have similar daily volatility (0.00).Check IVEVF's competition here
RVXCF vs FGHQF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, FGHQF has a market cap of 305M. Regarding current trading prices, RVXCF is priced at $0.08, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas FGHQF's P/E ratio is 14.98. In terms of profitability, RVXCF's ROE is +0.06%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, RVXCF and FGHQF have similar daily volatility (0.00).Check FGHQF's competition here
RVXCF vs PBBIF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, RVXCF is priced at $0.08, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, RVXCF's ROE is +0.06%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, RVXCF and PBBIF have similar daily volatility (0.00).Check PBBIF's competition here
RVXCF vs PRRUF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, PRRUF has a market cap of 278.9M. Regarding current trading prices, RVXCF is priced at $0.08, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas PRRUF's P/E ratio is -9.50. In terms of profitability, RVXCF's ROE is +0.06%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, RVXCF and PRRUF have similar daily volatility (0.00).Check PRRUF's competition here
RVXCF vs JWCTF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, JWCTF has a market cap of 267.7M. Regarding current trading prices, RVXCF is priced at $0.08, while JWCTF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas JWCTF's P/E ratio is -3.30. In terms of profitability, RVXCF's ROE is +0.06%, compared to JWCTF's ROE of -0.41%. Regarding short-term risk, RVXCF and JWCTF have similar daily volatility (0.00).Check JWCTF's competition here
RVXCF vs AVCTF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, AVCTF has a market cap of 257.8M. Regarding current trading prices, RVXCF is priced at $0.08, while AVCTF trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas AVCTF's P/E ratio is -5.84. In terms of profitability, RVXCF's ROE is +0.06%, compared to AVCTF's ROE of -3.40%. Regarding short-term risk, RVXCF and AVCTF have similar daily volatility (0.00).Check AVCTF's competition here
RVXCF vs ORYZF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ORYZF has a market cap of 254.2M. Regarding current trading prices, RVXCF is priced at $0.08, while ORYZF trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ORYZF's P/E ratio is -46.86. In terms of profitability, RVXCF's ROE is +0.06%, compared to ORYZF's ROE of -0.04%. Regarding short-term risk, RVXCF and ORYZF have similar daily volatility (0.00).Check ORYZF's competition here
RVXCF vs CLTEF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CLTEF has a market cap of 241.3M. Regarding current trading prices, RVXCF is priced at $0.08, while CLTEF trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CLTEF's P/E ratio is -3.37. In terms of profitability, RVXCF's ROE is +0.06%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, RVXCF is less volatile compared to CLTEF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check CLTEF's competition here
RVXCF vs SLNCF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, SLNCF has a market cap of 238.7M. Regarding current trading prices, RVXCF is priced at $0.08, while SLNCF trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas SLNCF's P/E ratio is -3.30. In terms of profitability, RVXCF's ROE is +0.06%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, RVXCF and SLNCF have similar daily volatility (0.00).Check SLNCF's competition here
RVXCF vs SPHDF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, SPHDF has a market cap of 238.3M. Regarding current trading prices, RVXCF is priced at $0.08, while SPHDF trades at $18.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas SPHDF's P/E ratio is -4.03. In terms of profitability, RVXCF's ROE is +0.06%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, RVXCF and SPHDF have similar daily volatility (0.00).Check SPHDF's competition here
RVXCF vs HNSBF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, HNSBF has a market cap of 232.3M. Regarding current trading prices, RVXCF is priced at $0.08, while HNSBF trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas HNSBF's P/E ratio is -3.08. In terms of profitability, RVXCF's ROE is +0.06%, compared to HNSBF's ROE of +1.21%. Regarding short-term risk, RVXCF and HNSBF have similar daily volatility (0.00).Check HNSBF's competition here
RVXCF vs NWPHF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, RVXCF is priced at $0.08, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas NWPHF's P/E ratio is N/A. In terms of profitability, RVXCF's ROE is +0.06%, compared to NWPHF's ROE of N/A. Regarding short-term risk, RVXCF and NWPHF have similar daily volatility (0.00).Check NWPHF's competition here
RVXCF vs MDCLF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, MDCLF has a market cap of 230.7M. Regarding current trading prices, RVXCF is priced at $0.08, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, RVXCF's ROE is +0.06%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, RVXCF and MDCLF have similar daily volatility (0.00).Check MDCLF's competition here
RVXCF vs CMVLF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CMVLF has a market cap of 224.9M. Regarding current trading prices, RVXCF is priced at $0.08, while CMVLF trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CMVLF's P/E ratio is -5.29. In terms of profitability, RVXCF's ROE is +0.06%, compared to CMVLF's ROE of -0.46%. Regarding short-term risk, RVXCF and CMVLF have similar daily volatility (0.00).Check CMVLF's competition here
RVXCF vs MLPH Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, MLPH has a market cap of 223.1M. Regarding current trading prices, RVXCF is priced at $0.08, while MLPH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas MLPH's P/E ratio is N/A. In terms of profitability, RVXCF's ROE is +0.06%, compared to MLPH's ROE of +0.00%. Regarding short-term risk, RVXCF and MLPH have similar daily volatility (0.00).Check MLPH's competition here
RVXCF vs BOVNF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, RVXCF is priced at $0.08, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BOVNF's P/E ratio is -4.44. In terms of profitability, RVXCF's ROE is +0.06%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, RVXCF and BOVNF have similar daily volatility (0.00).Check BOVNF's competition here
RVXCF vs FPHAF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, RVXCF is priced at $0.08, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, RVXCF's ROE is +0.06%, compared to FPHAF's ROE of N/A. Regarding short-term risk, RVXCF and FPHAF have similar daily volatility (0.00).Check FPHAF's competition here
RVXCF vs BXPHF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BXPHF has a market cap of 208.8M. Regarding current trading prices, RVXCF is priced at $0.08, while BXPHF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BXPHF's P/E ratio is -10.64. In terms of profitability, RVXCF's ROE is +0.06%, compared to BXPHF's ROE of -0.21%. Regarding short-term risk, RVXCF and BXPHF have similar daily volatility (0.00).Check BXPHF's competition here
RVXCF vs VSBC Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, RVXCF is priced at $0.08, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas VSBC's P/E ratio is N/A. In terms of profitability, RVXCF's ROE is +0.06%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, RVXCF and VSBC have similar daily volatility (0.00).Check VSBC's competition here
RVXCF vs CAIHF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, CAIHF has a market cap of 206.2M. Regarding current trading prices, RVXCF is priced at $0.08, while CAIHF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas CAIHF's P/E ratio is 7.00. In terms of profitability, RVXCF's ROE is +0.06%, compared to CAIHF's ROE of +0.05%. Regarding short-term risk, RVXCF and CAIHF have similar daily volatility (0.00).Check CAIHF's competition here
RVXCF vs GNFTF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, GNFTF has a market cap of 185.2M. Regarding current trading prices, RVXCF is priced at $0.08, while GNFTF trades at $3.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas GNFTF's P/E ratio is 124.00. In terms of profitability, RVXCF's ROE is +0.06%, compared to GNFTF's ROE of +0.02%. Regarding short-term risk, RVXCF and GNFTF have similar daily volatility (0.00).Check GNFTF's competition here
RVXCF vs BRIBF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BRIBF has a market cap of 176.1M. Regarding current trading prices, RVXCF is priced at $0.08, while BRIBF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BRIBF's P/E ratio is -2.41. In terms of profitability, RVXCF's ROE is +0.06%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, RVXCF and BRIBF have similar daily volatility (0.00).Check BRIBF's competition here
RVXCF vs ADOCY Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, RVXCF is priced at $0.08, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, RVXCF's ROE is +0.06%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, RVXCF and ADOCY have similar daily volatility (0.00).Check ADOCY's competition here
RVXCF vs BSEM Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, BSEM has a market cap of 167.1M. Regarding current trading prices, RVXCF is priced at $0.08, while BSEM trades at $10.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas BSEM's P/E ratio is 6.96. In terms of profitability, RVXCF's ROE is +0.06%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, RVXCF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check BSEM's competition here
RVXCF vs OPORF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, RVXCF is priced at $0.08, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas OPORF's P/E ratio is 12.00. In terms of profitability, RVXCF's ROE is +0.06%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, RVXCF and OPORF have similar daily volatility (0.00).Check OPORF's competition here
RVXCF vs NGENF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, NGENF has a market cap of 162.2M. Regarding current trading prices, RVXCF is priced at $0.08, while NGENF trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas NGENF's P/E ratio is -7.93. In terms of profitability, RVXCF's ROE is +0.06%, compared to NGENF's ROE of -4.00%. Regarding short-term risk, RVXCF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check NGENF's competition here
RVXCF vs MLLCF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, RVXCF is priced at $0.08, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas MLLCF's P/E ratio is -1.98. In terms of profitability, RVXCF's ROE is +0.06%, compared to MLLCF's ROE of -0.42%. Regarding short-term risk, RVXCF and MLLCF have similar daily volatility (0.00).Check MLLCF's competition here
RVXCF vs SCNLF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, SCNLF has a market cap of 150.5M. Regarding current trading prices, RVXCF is priced at $0.08, while SCNLF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas SCNLF's P/E ratio is -4.83. In terms of profitability, RVXCF's ROE is +0.06%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, RVXCF and SCNLF have similar daily volatility (0.00).Check SCNLF's competition here
RVXCF vs AMGXF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, AMGXF has a market cap of 128.9M. Regarding current trading prices, RVXCF is priced at $0.08, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, RVXCF's ROE is +0.06%, compared to AMGXF's ROE of -0.14%. Regarding short-term risk, RVXCF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check AMGXF's competition here
RVXCF vs AAPGV Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, RVXCF is priced at $0.08, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas AAPGV's P/E ratio is N/A. In terms of profitability, RVXCF's ROE is +0.06%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, RVXCF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check AAPGV's competition here
RVXCF vs IPHYF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, IPHYF has a market cap of 120.7M. Regarding current trading prices, RVXCF is priced at $0.08, while IPHYF trades at $1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas IPHYF's P/E ratio is -1.85. In terms of profitability, RVXCF's ROE is +0.06%, compared to IPHYF's ROE of -2.63%. Regarding short-term risk, RVXCF and IPHYF have similar daily volatility (0.00).Check IPHYF's competition here
RVXCF vs PSTTF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, RVXCF is priced at $0.08, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, RVXCF's ROE is +0.06%, compared to PSTTF's ROE of N/A. Regarding short-term risk, RVXCF and PSTTF have similar daily volatility (0.00).Check PSTTF's competition here
RVXCF vs EPRXF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, RVXCF is priced at $0.08, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, RVXCF's ROE is +0.06%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, RVXCF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check EPRXF's competition here
RVXCF vs ADOIF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, RVXCF is priced at $0.08, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, RVXCF's ROE is +0.06%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, RVXCF and ADOIF have similar daily volatility (0.00).Check ADOIF's competition here
RVXCF vs TRGNF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, TRGNF has a market cap of 92.7M. Regarding current trading prices, RVXCF is priced at $0.08, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas TRGNF's P/E ratio is -2.06. In terms of profitability, RVXCF's ROE is +0.06%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, RVXCF and TRGNF have similar daily volatility (0.00).Check TRGNF's competition here
RVXCF vs PBIGF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, PBIGF has a market cap of 90.9M. Regarding current trading prices, RVXCF is priced at $0.08, while PBIGF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas PBIGF's P/E ratio is -7.62. In terms of profitability, RVXCF's ROE is +0.06%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, RVXCF and PBIGF have similar daily volatility (0.00).Check PBIGF's competition here
RVXCF vs MCURF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, RVXCF is priced at $0.08, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas MCURF's P/E ratio is -16.90. In terms of profitability, RVXCF's ROE is +0.06%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, RVXCF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check MCURF's competition here
RVXCF vs ACHFF Comparison August 2025
RVXCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RVXCF stands at 17.4M. In comparison, ACHFF has a market cap of 82.2M. Regarding current trading prices, RVXCF is priced at $0.08, while ACHFF trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RVXCF currently has a P/E ratio of -6.10, whereas ACHFF's P/E ratio is -41.47. In terms of profitability, RVXCF's ROE is +0.06%, compared to ACHFF's ROE of +0.53%. Regarding short-term risk, RVXCF is less volatile compared to ACHFF. This indicates potentially lower risk in terms of short-term price fluctuations for RVXCF.Check ACHFF's competition here